<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01869790</url>
  </required_header>
  <id_info>
    <org_study_id>Prandial bolus coverage</org_study_id>
    <nct_id>NCT01869790</nct_id>
  </id_info>
  <brief_title>Evaluation of Fats on Postprandial Glucose Control</brief_title>
  <acronym>Nabucco</acronym>
  <official_title>Development of &quot;Fat&quot; Bolus for Coverage of Higher Fat Meals.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Joslin Diabetes Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Boston Children's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Joslin Diabetes Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is examine the effect of different fat types on postprandial&#xD;
      glucose control in patients with type 1 diabetes.&#xD;
&#xD;
      Subjects will have several admissions and, in random order, will receive lunches with&#xD;
      identical carbohydrate content but different fat content: lunch A will minimal fat content,&#xD;
      lunch B will contain added butter, lunch C will contain added olive oil, and lunch D will&#xD;
      contain added cheese. Total fat content in lunches B-D will be the same. Subjects will&#xD;
      receive identical insulin doses (calculated using the subject's usual insulin-to-carbohydrate&#xD;
      ratio) for the meals.&#xD;
&#xD;
      The investigators hypothesize that, despite identical carbohydrate content,the lunches higher&#xD;
      in saturated fat will lead to more postprandial hyperglycemia than the lunch containing&#xD;
      minimal fat and the lunch high in monounsaturated fat.&#xD;
&#xD;
      The hypothesis is that from time points 0-180 minute area under the curve for Lunches A, B,&#xD;
      C, and D will be the same, whereas from time points 180-360 minutes for Lunch B and D will be&#xD;
      greater than that of Lunch A and C.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Subjects for this study will be adults with type 1 diabetes who use insulin pump in their&#xD;
      diabetes self-management. Prior to admission the the clinical research center the basal rates&#xD;
      and insulin-to-carbohydrate ratio of the subjects will be optimized using standard clinical&#xD;
      procedures.&#xD;
&#xD;
      Subjects will be admitted to the clinical research center in mid-morning following a light&#xD;
      breakfast at home. Subjects will have several admissions and, in random order, will receive&#xD;
      lunches with identical carbohydrate content but different fat content: lunch A will minimal&#xD;
      fat content, lunch B will contain added butter, lunch C will contain added olive oil, and&#xD;
      lunch D will contain added cheese. Total fat content in lunches B-D will be the same.&#xD;
      Subjects will receive identical insulin doses (calculated using the subject's usual&#xD;
      insulin-to-carbohydrate ratio) for the meals. Blood samples for measurement of plasma glucose&#xD;
      and insulin levels will be drawn for the subsequent 6 hours. We hypothesize that postprandial&#xD;
      glucose levels 3-6 hours after start of the meal will be higher following lunches B and D,&#xD;
      compared to lunches A and C.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2013</start_date>
  <completion_date type="Actual">April 2015</completion_date>
  <primary_completion_date type="Actual">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Area under the curve (AUC)</measure>
    <time_frame>0-180 minutes vs 180-360 minutes</time_frame>
    <description>One-way repeated measures ANOVA will be used to analyze area under curve differences between the three lunches as well as time in target range (80-180 mg/dL), peak blood glucose, time to peak blood glucose, time to return to baseline blood glucose.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">10</enrollment>
  <condition>Type 1 Diabetes</condition>
  <arm_group>
    <arm_group_label>Meal challenge</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Different fat types</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Different fat types</intervention_name>
    <description>Saturated, monounsaturated fats</description>
    <arm_group_label>Meal challenge</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adult patients (aged 18-75 years) with type 1 diabetes &gt; 3 years.&#xD;
&#xD;
          -  On insulin pump therapy.&#xD;
&#xD;
          -  A1c &lt; 8.5%.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  History or symptoms suggestive of gastric dysmotility, celiac disease, pancreatic&#xD;
             exocrine dysfunction or other conditions that cause malabsorption or maldigestion.&#xD;
&#xD;
          -  Eating disorder.&#xD;
&#xD;
          -  Diet allergies.&#xD;
&#xD;
          -  Special diet restrictions, such as vegan or any nut allergy.&#xD;
&#xD;
          -  Medications know to affect insulin sensitivity (such as glucocorticoids) or affect&#xD;
             gastrointestinal motility (such as reglan).&#xD;
&#xD;
          -  High-titre insulin autoantibodies with delayed insulin kinetics.&#xD;
&#xD;
          -  Women who are breast feeding, pregnant, or wanting to become pregnant.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Howard Wolpert, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Joslin Diabetes Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Joslin Diabetes Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02215</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2017</verification_date>
  <study_first_submitted>June 2, 2013</study_first_submitted>
  <study_first_submitted_qc>June 2, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 5, 2013</study_first_posted>
  <last_update_submitted>April 25, 2017</last_update_submitted>
  <last_update_submitted_qc>April 25, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 26, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus, Type 1</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

